STRS Ohio’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.04M | Hold |
42,000
| – | – | ﹤0.01% | 703 |
|
|
2025
Q4 | $980K | Sell |
42,000
-5,300
| -11% | -$118K | ﹤0.01% | 708 |
|
|
2025
Q3 | $932K | Buy |
47,300
+4,600
| +11% | +$94.6K | ﹤0.01% | 713 |
|
|
2025
Q2 | $927K | Buy |
42,700
+1,700
| +4% | +$40.1K | ﹤0.01% | 951 |
|
|
2025
Q1 | $994K | Sell |
41,000
-3,200
| -7% | -$72.1K | ﹤0.01% | 873 |
|
|
2024
Q4 | $922K | Sell |
44,200
-700
| -2% | -$15K | ﹤0.01% | 883 |
|
|
2024
Q3 | $893K | Sell |
44,900
-6,300
| -12% | -$117K | ﹤0.01% | 946 |
|
|
2024
Q2 | $793K | Buy |
51,200
+2,900
| +6% | +$45.1K | ﹤0.01% | 966 |
|
|
2024
Q1 | $769K | Sell |
48,300
-7,800
| -14% | -$118K | ﹤0.01% | 1009 |
|
|
2023
Q4 | $943K | Sell |
56,100
-3,100
| -5% | -$42.4K | ﹤0.01% | 931 |
|
|
2023
Q3 | $692K | Hold |
59,200
| – | – | ﹤0.01% | 1052 |
|
|
2023
Q2 | $795K | Buy |
59,200
+6,900
| +13% | +$99.3K | ﹤0.01% | 1026 |
|
|
2023
Q1 | $867K | Buy |
52,300
+3,600
| +7% | +$59.4K | ﹤0.01% | 997 |
|
|
2022
Q4 | $905K | Sell |
48,700
-13,700
| -22% | -$211K | ﹤0.01% | 975 |
|
|
2022
Q3 | $800K | Sell |
62,400
-40,100
| -39% | -$475K | ﹤0.01% | 1031 |
|
|
2022
Q2 | $718K | Sell |
102,500
-2,200
| -2% | -$16.1K | ﹤0.01% | 1121 |
|
|
2022
Q1 | $867K | Sell |
104,700
-22,100
| -17% | -$156K | ﹤0.01% | 1120 |
|
|
2021
Q4 | $858K | Sell |
126,800
-33,200
| -21% | -$218K | ﹤0.01% | 1212 |
|
|
2021
Q3 | $848K | Buy |
160,000
+16,500
| +11% | +$90.2K | ﹤0.01% | 1211 |
|
|
2021
Q2 | $825K | Sell |
143,500
-51,300
| -26% | -$265K | ﹤0.01% | 1298 |
|
|
2021
Q1 | $898K | Buy |
194,800
+15,000
| +8% | +$59.6K | ﹤0.01% | 1230 |
|
|
2020
Q4 | $600K | Buy |
179,800
+12,100
| +7% | +$40.6K | ﹤0.01% | 1375 |
|
|
2020
Q3 | $498K | Buy |
167,700
+45,600
| +37% | +$178K | ﹤0.01% | 1335 |
|
|
2020
Q2 | $564K | Sell |
122,100
-27,000
| -18% | -$121K | ﹤0.01% | 1218 |
|
|
2020
Q1 | $574K | Hold |
149,100
| – | – | ﹤0.01% | 1034 |
|
|
2019
Q4 | $559K | Buy |
149,100
+29,200
| +24% | +$137K | ﹤0.01% | 1391 |
|
|
2019
Q3 | $636K | Sell |
119,900
-48,600
| -29% | -$259K | ﹤0.01% | 1067 |
|
|
2019
Q2 | $647K | Sell |
168,500
-22,100
| -12% | -$95.5K | ﹤0.01% | 1091 |
|
|
2019
Q1 | $972K | Hold |
190,600
| – | – | ﹤0.01% | 834 |
|
|
2018
Q4 | $365K | Hold |
190,600
| – | – | ﹤0.01% | 1417 |
|
|
2018
Q3 | $720K | Sell |
190,600
-32,500
| -15% | -$102K | ﹤0.01% | 1122 |
|
|
2018
Q2 | $696K | Hold |
223,100
| – | – | ﹤0.01% | 1195 |
|
|
2018
Q1 | $533K | Buy |
223,100
+60,100
| +37% | +$200K | ﹤0.01% | 1292 |
|
|
2017
Q4 | $637K | Buy |
+163,000
| New | +$539K | ﹤0.01% | 1213 |
|
|
2016
Q2 | – | Sell |
-24,100
| Closed | -$28K | – | 1930 |
|
|
2016
Q1 | $28K | Hold |
24,100
| – | – | ﹤0.01% | 1808 |
|
|
2015
Q4 | $59K | Hold |
24,100
| – | – | ﹤0.01% | 1767 |
|
|
2015
Q3 | $72K | Hold |
24,100
| – | – | ﹤0.01% | 1714 |
|
|
2015
Q2 | $99K | Buy |
+24,100
| New | +$96.1K | ﹤0.01% | 1682 |
|
Other funds holding CPRX
VCM
DM
VPM
STRS Ohio's CPRX Position: Q1 2026 in Review
STRS Ohio held its Catalyst Pharmaceutical (CPRX) position steady in Q1 2026 at 42,000 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #703.
STRS Ohio first reported a position in CPRX in Q2 2015 and has held it in 38 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- STRS Ohio held 42,000 shares of Catalyst Pharmaceutical worth $1.04M as of Q1 2026.
- STRS Ohio left its Catalyst Pharmaceutical share count unchanged in Q1 2026.
- Catalyst Pharmaceutical made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #703 holding.
- STRS Ohio first reported a position in Catalyst Pharmaceutical in Q2 2015 and has held it in 38 quarters since.
- 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.